SCHEMBL26705254

SCHEMBL26705254

CCOC(=O)CC1Oc2ccccc2C1C(C(C)=O)C(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
ALDH1A1 P00352 5/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
RAB9A P51151 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 2/20 0.36
IDO1 P14902 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22877184 0.94 POLB (0.44) POLBALDH1A1CYP1A2MEN1KMT2A
SCHEMBL26429458 0.89 ALDH1A1 (0.40) POLBALDH1A1LMNAMEN1KMT2A
SCHEMBL22877348 0.86 TSHR (0.39) POLBALDH1A1LMNAKMT2ATDP1
SCHEMBL26429710 0.77 L3MBTL1 (0.38) POLBALDH1A1LMNACYP1A2KMT2A
SCHEMBL26429453 0.73 MTNR1A (0.39) ALDH1A1LMNACYP1A2TDP1HPGD
SCHEMBL26705039 0.73 POLB (0.39) POLBALDH1A1LMNANPC1
SCHEMBL26429440 0.72 CYP2D6 (0.40) ALDH1A1LMNATDP1KDM4EHPGD
SCHEMBL22992514 0.69 POLB (0.47) POLBALDH1A1CYP1A2MEN1KMT2A
SCHEMBL22992503 0.69 POLB (0.47) POLBALDH1A1CYP1A2MEN1KMT2A
SCHEMBL26429429 0.68 SLC6A2 (0.37) ALDH1A1MEN1KMT2ARAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339879-A1 SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS NORTHWESTERN UNIVERSITY 2023-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339879-A1 SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS TYR, ME1, PNPO POLB 1799/4885ALDH1A1 444/4885LMNA 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.